Skip to content

Author

Nicholas E. Johnson

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

This review highlights genetically targeted therapeutics showing impact for muscle manifestations of DM1, ongoing efforts now shifting to expand to other target tissues and the younger population, and the understanding of societal burden and population genetics of DM1.

Samuel Carrell, Adam D. Comer, Nicholas E. Johnson · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.